Pimozide online
Les effets indésirables les effets indésirables les plus communs associés à pimozide sont le sommeil, la migraine, le revers d'estomac, l'étroitesse de muscle, la faiblesse de muscle, le mouvement de difficulté, le tremblement, la conduite anormale, les troubles visuels et l'impuissance et acheter piracetam generique medicaments.
De méd. gén. 6, 0 4, 0 18, 1 -2, 5 0, 9 -6, 5 -2, 9.
1. Jankovic J. Tourette's syndrome. N Engl J Med 2001 ; 345 : 118492. 2. Sallee FR, Nesbitt L, Jackson C et al. Relative efficacy of haloperidol and pimozide in children and adolescents with Tourette's disorder. J Psychiatry 1997 ; 154 : 1057-62. 3. Short-term versus longer term pimozide therapy in Tourette's syndrome : a preliminary study. Neurology 1999 ; 52 : 874-77. 4. Dion Y, Annable L, Sandor P, Chouinard G. Risperidone in the treatment of tourette syndrome : a double-blind, placebo-controlled trial. J Clin Psychopharmacol 2002 ; 22 : 31-39. 5. Bruggeman R, van der Linden C, Buitelaar JK et al. Risperidone versus pimozide in Tourette's disorder : a comparative double-blind parallel-group study. J Clin Psychiatry 2001 ; 62 : 50-56. 6. Singer HS. Current issues in Tourette syndrome. Mov Disord 2000 ; 15 : 1051-63. 7. Onofrj M, Paci C, D'Andreamatteo G, Toma L. Olanzapine in severe Gilles de la Tourette syndrome : a 52-week double-blind cross-over study vs. low-dose pimozide. J Neurol 2000 ; 247 : 443-46. 8. Jankovic J, Beach J. Long-term effects of tetrabenazine in hyperkinetic movement disorders. Neurology 1997 ; 48 : 358-62. 9. Gilbert DL, Sethuraman G, Sine L, Peters S, Sallee FR. Tourette's syndrome improvement with pergolide in a randomized, double-blind, crossover trial. Neurology 2000 ; 54 : 1310-15. 10. Lipinski JF, Sallee FR, Jackson C, Sethuraman G. Dopamine agonist treatment of Tourette disorder in children : results of an openlabel trial of pergolide. Mov Disord 1997 ; 12 : 402-7. 11. Black KJ, Mink JW. Response to levodopa challenge in Tourette syndrome. Mov Disord 2000 ; 15 : 1194-98. 12. Glass M, Brotchie JM, Maneuf YP. Modulation of neurotransmission by cannabinoids in the basal ganglia. Eur J Neurosci 1997 ; 9 : 199-203. 13. Muller-Vahl KR, Kolbe H, Schneider U, Emrich HM. Cannabinoids : possible role in patho-physiology and therapy of Gilles de la Tourette syndrome. Acta Psychiatr Scand 1998 98 : 502-06. 14. Muller-Vahl KR, Koblenz A, Jobges M. et al. Influence of treatment of Tourette syndrome with delta9-tetrahydrocannabinol delta9-THC ; on neuropsychological performance. Pharmacopsychiatry 2001 ; 34 : 19-24. 15. Silver AA, Shytle RD, Philipp MK, et al. Transdermal nicotine and haloperidol in Tourette's disorder : a double-blind placebo-controlled study. J Clin Psychiatry 2001 ; 62 : 707-14. 16. Hoopes SP. Donepezil for Tourette's disorder and ADHD. J Clin Psychopharmacol 1999 ; 19 : 381-82. 17. Silver AA, Shytle RD, Sheehan KH et al. Multicenter, double-blind, placebo-controlled study of mecamylamine monotherapy for Tourette's disorder. J Acad Child Adolesc Psychiatry 2001 ; 40 : 1103-10. 18. Gonce M, Barbeau A. Seven cases of Gilles de la tourette's syndrome: partial relief with clonazepam : a pilot study. Can J Neurol Sci 1977 ; 4 : 279-83. 19. Steingard RJ, Goldberg M, Lee D, DeMaso Dr Adjunctive clonazepam treatment of tic symptoms in children with comorbid tic disorders and ADHD. J Acad Child Adolesc Psychiatry 1994 ; 33 : 394-99. 20. Goetz CG. Clonidine and clonazepam in Tourette syndrome. Adv Neurol 1992 ; 58 : 245-51. 21. Singer HS, Wendlandt J, Krieger M, Giuliano J. Baclofen treatment in Tourette syndrome : a double-blind, placebo-controlled, crossover trial. Neurology 2001 ; 56 : 599-604. 22. Treatment of ADHD in children with tics : A randomized controlled trial. Neurology 2002 ; 58 : 527-36. 23. Goetz CG, Tanner CM, Wilson RS et al. Clonidine and Gilles de la Tourette's syndrome : double-blind study using objective rating methods. Ann Neurol 1987 ; 21 : 307-10. 24. Gaffney GR, Perry PJ, Lund BC et al. Risperidone versus clonidine in the treatment of children and adolescents with Tourette's syndrome. J Acad Child Adolesc Psychiatry 2002 ; 41 : 330-36. 25. Scahill L, Chappell PB, Kim YS et al. A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder. J Psychiatry 2001; 158: 106774. Kwak CH, Hanna PA, Jankovic J. Botulinum toxin in the treatment of tics. Arch Neurol 2000 ; 57 : 1190-93. 27. Marras C, Andrews D, Sime E, Lang AE. Botulinum toxin for simple motor tics : a randomized, double-blind, controlled clinical trial. Neurology 2001 ; 56 : 605-10. 28. Robertson MM. Tourette syndrome, associated conditions and the complexities of treatment. Brain 2000 ; 123 Pt 3 ; : 425-62. 29. Perlmutter SJ, Leitman SF, Garvey MA et al. Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood. Lancet 1999 ; 354 : 1 153-58. 30. Weiden P, Bruun R. Worsening of Tourette's disorder due to neuroleptic-induced akathisia. J Psychiatry 1987 ; 144 : 504-05 et acheter plendil en ligne.
| La Pimozide[21] 2, 250, 600 [13] A1 [51] Int.Cl. 6A61K 31 245 [25] EN [54] ORAL ANALGESIC COMPOSITIONS [54] COMPOSITIONS ANALGESIQUES ORALES [72] RATNARAJ, Teresa Rita, US [72] SANDLER, Patricia Lynn, US [72] KAY, Martha Francine, US [71] AMERICAN HOME PRODUCTS CORPORATION, US [22] 1998-10-16 [43] 1999-04-17 [30] US 08 953, 146 ; 1997-10-17.
Pimozide ajoutera aux effets d'alcool et d'autres dépresseurs et potassium.
Le fait de bàiller excessif, le seul effet indésirable rencontré, était la dose rattachée et a été aboli avec l'adjonction de pimozide au régime de médicament.
|